Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension - Business Wire

Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension  Business Wire

Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the efficacy and safety of intravenous (IV) sildenafil when added to inhaled ni.



Comments

Popular posts from this blog

What Taking Aspirin Every Day Does to Your Body | Eat This Not That - Eat This, Not That

Montelukast oral tablet side effects: How to manage them